|
116
|
435
|
1rt1B |
Crystal structure of hiv-1 reverse transcriptase complexed with mkc-442 |
|
113
|
424
|
1rt3B |
Azt drug resistant hiv-1 reverse transcriptase complexed with 1051u91 |
|
114
|
427
|
1revB |
Hiv-1 reverse transcriptase |
|
20
|
99
|
1rl8A |
Crystal structure of the complex of resistant strain of hiv-1 protease(v82a mutant) with ritonavir |
|
107
|
427
|
1rt2B |
Crystal structure of hiv-1 reverse transcriptase complexed with tnk-651 |
|
145
|
536
|
1revA |
Hiv-1 reverse transcriptase |
|
15
|
99
|
1qbsA |
Hiv-1 protease inhibitors wiih low nanomolar potency |
|
47
|
154
|
1qs4A |
Core domain of hiv-1 integrase complexed with mg++ and 1-(5-chloroindol-3-yl)-3-hydroxy-3-(2h-tetrazol-5-yl)-propenone |
|
18
|
99
|
1qbuA |
Hiv-1 protease inhibitors wiih low nanomolar potency |
|
121
|
556
|
1qe1A |
Crystal structure of 3tc-resistant m184i mutant of hiv-1 reverse transcriptase |
|
5
|
52
|
1qmcA |
C-terminal dna-binding domain of hiv-1 integrase, nmr, 42 structures |
|
88
|
427
|
1qe1B |
Crystal structure of 3tc-resistant m184i mutant of hiv-1 reverse transcriptase |
|
16
|
99
|
1qbtA |
Hiv-1 protease inhibitors wiih low nanomolar potency |
|
17
|
99
|
1qbrA |
Hiv-1 protease inhibitors wiih low nanomolar potency |
|
7
|
95
|
1q9pA |
Solution structure of the mature hiv-1 protease monomer |
|
17
|
99
|
1proA |
Hiv-1 protease dimer complexed with a-98881 |
|
15
|
99
|
1odxA |
Hiv-1 proteinase mutant a71t, v82a |
|
17
|
99
|
1odyA |
Hiv-1 protease complexed with an inhibitor lp-130 |
|
17
|
99
|
1odwA |
Native hiv-1 proteinase |
|
71
|
251
|
1nndA |
Arginine 116 is essential for nucleic acid recognition by the fingers domain of moloney murine leukemia virus reverse transcriptase |
|
26
|
138
|
1o1wA |
Solution structure of the rnase h domain of the hiv-1 reverse transcriptase in the presence of magnesium |
|
17
|
99
|
1nh0A |
1.03 a structure of hiv-1 protease: inhibitor binding inside and outside the active site |
|
15
|
99
|
1npaA |
Crystal structure of hiv-1 protease-hup |
|
15
|
99
|
1npwA |
Crystal structure of hiv protease complexed with lgz479 |
|
15
|
99
|
1npvA |
Crystal structure of hiv-1 protease complexed with ldc271 |
|
0
|
17
|
1ncpN |
Structural characterization of a 39 residue synthetic peptide containing the two zinc binding domains from the hiv-1 p7 nucleocapsid protein by cd and nmr spectroscopy |
|
3
|
29
|
1nc8A |
High-resolution solution nmr structure of the minimal active domain of the human immunodeficiency virus type-2 nucleocapsid protein, 15 structures |
|
0
|
18
|
1ncpC |
Structural characterization of a 39 residue synthetic peptide containing the two zinc binding domains from the hiv-1 p7 nucleocapsid protein by cd and nmr spectroscopy |
|
17
|
99
|
1mt8A |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
18
|
99
|
1mt7A |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
13
|
99
|
1mrxA |
Structure of hiv protease (mutant q7k l33i l63i v82f i84v ) complexed with kni-577 |
|
17
|
99
|
1mtbA |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
16
|
99
|
1mtrA |
Hiv-1 protease complexed with a cyclic phe-ile-val peptidomimetic inhibitor |
|
117
|
426
|
1mu2B |
Crystal structure of hiv-2 reverse transcriptase |
|
73
|
251
|
1mmlA |
Mechanistic implications from the structure of a catalytic fragment of mmlv reverse transcriptase |
|
13
|
99
|
1n49A |
Viability of a drug-resistant hiv-1 protease variant: structural insights for better anti-viral therapy |
|
15
|
99
|
1msmA |
The hiv protease (mutant q7k l33i l63i) complexed with kni-764 (an inhibitor) |
|
18
|
99
|
1mt9A |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
150
|
553
|
1mu2A |
Crystal structure of hiv-2 reverse transcriptase |
|
14
|
99
|
1mrwA |
Structure of hiv protease (mutant q7k l33i l63i) complexed with kni-577 |
|
15
|
99
|
1msnA |
The hiv protease (mutant q7k l33i l63i v82f i84v) complexed with kni-764 (an inhibitor) |
|
117
|
423
|
1lwcB |
Crystal structure of m184v mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
16
|
99
|
1meuA |
Hiv-1 mutant (v82f, i84v) protease complexed with dmp323 |
|
146
|
534
|
1lw0A |
Crystal structure of t215y mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
16
|
99
|
1lzqA |
Crystal structure of the complex of mutant hiv-1 protease (a71v, v82t, i84v) with an ethylenamine peptidomimetic inhibitor boc-phe-psi[ch2ch2nh]-phe-glu-phe-nh2 |
|
49
|
146
|
1m9dC |
X-ray crystal structure of cyclophilin a/hiv-1 ca n-terminal domain (1-146) o-type chimera complex. |
|
144
|
554
|
1lwfA |
Crystal structure of a mutant hiv-1 reverse transcriptase (rtmq+m184v: m41l/d67n/k70r/m184v/t215y) in complex with nevirapine |
|
47
|
203
|
1lv1A |
Crystal structure analysis of the non-active site mutant of tethered hiv-1 protease to 2.1a resolution |
|
146
|
534
|
1lwcA |
Crystal structure of m184v mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
134
|
554
|
1lweA |
Crystal structure of m41l/t215y mutant hiv-1 reverse transcriptase (rtmn) in complex with nevirapine |
